Today is the first official day of the new Merck - a result of its combination with Schering-Plough . A note to investors from analysts at Leerink Swann says "the combined MRK/SGP entity has one of the most robust late-stage pipelines in all of big pharma." But before you pop the champage to celebrate the new baby, consider that the rest of the ...